[1] 郭宁如,吴绍熙,吕桂霞,等.胸腺肤对小鼠白色念珠菌作用的初步研究.中国医学科学院学报,1986.8:399.
[2] Rogers TE. Galgiani JN. Activity of fluconazole (UK49,858)and ketoconazole against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother,1986,30:418.
[3] Yamaguchi H, Uchida K, Kawasake K, et al. In vitro activity of fluconazole a novel bistriazole antifungal agent. Japn J Antibiotics,1989.42:1.
[4] Hughes CE,Bennett RL,Tuna RC,et al. Activities of fiuconazole and ketoconazole against ketoconazole susceptible and resistant Candida albicans. Antimicrob Agents Chemother.1988.32:209.
[5] Cook RE,McIntyre KA,Galgiani JN. Effects of incubation temperature, inoculum size and medium on agreement of macro-and microdilution broth susceptibility test results for yeasts. Antibiot Chemother.1990,34:1542.
[6] Galgiani JN. Antifungal susceptibility tests. Antimicrob Agents Chemother,1987,31:1867.
[7] Shiba K,Sailo A,Miyzhara T,et al. Pharmacokinetics evaluation of fluconazole in health volunteers. Japn J Antibiotics, 1989. 42:17.
[8] Richardson K.Brammer KW,Marriott MS.et al. Activity of UK-49,858.a bistriazole derivative,against experimental infections with Candida and Trichophyton mentagrophytes. Antimicrob Agents Chemother,1985,27:832.
[9] Ttoke PF,Smith MJ. Efficiency of fluconazole against experimental aspergillosis and Cryptococcosis in mice J Antimicrob Chmother,1987.19:663.
[10] Pfaller MA,Rinaldi MG,Galgiani JN,et al. Collaborative investigation of variables in susceptibility testing of yeasts. Antimicrob Agents Chemother, 1990, 34:1648. |